Mepur H. Ravindranath
Department of Glycoimmunotherapy
John Wayne Cancer Institute
2200 Santa Monica Blvd.
Santa Monica
USA
Name/email consistency: high
- Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy. Ravindranath, M.H., Muthugounder, S., Hannah, M.R., Morton, D.L. Ann. N. Y. Acad. Sci. (2007)
- Glycoimmunomics of human cancer: current concepts and future perspectives. Ravindranath, M.H., Yesowitch, P., Sumobay, C., Morton, D.L. Future. Oncol (2007)
- Immunogenic gangliosides in human ovarian carcinoma. Ravindranath, M.H., Muthugounder, S., Presser, N., Selvan, S.R., Santin, A.D., Bellone, S., Saravanan, T.S., Morton, D.L. Biochem. Biophys. Res. Commun. (2007)
- Endogenous immune response to gangliosides in patients with confined prostate cancer. Ravindranath, M.H., Muthugounder, S., Presser, N., Ye, X., Brosman, S., Morton, D.L. Int. J. Cancer (2005)
- Human antiganglioside autoantibodies: validation of ELISA. Ravindranath, M.H., Muthugounder, S., Saravanan, T.S., Presser, N., Morton, D.L. Ann. N. Y. Acad. Sci. (2005)
- Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Ravindranath, M.H., Muthugounder, S., Presser, N., Selvan, S.R., Portoukalian, J., Brosman, S., Morton, D.L. Biochem. Biophys. Res. Commun. (2004)